Search by Drug Name or NDC

    NDC 00067-6095-01 THERAFLU 650; 25; 10 mg/1; mg/1; mg/1 Details

    THERAFLU 650; 25; 10 mg/1; mg/1; mg/1

    THERAFLU is a ORAL POWDER, FOR SOLUTION in the HUMAN OTC DRUG category. It is labeled and distributed by GlaxoSmithKline Consumer Healthcare Holdings (US) LLC. The primary component is ACETAMINOPHEN; DIPHENHYDRAMINE HYDROCHLORIDE; PHENYLEPHRINE HYDROCHLORIDE.

    Product Information

    NDC 00067-6095
    Product ID 0067-6095_6aaf7108-4983-4951-901e-11bc65ccc933
    Associated GPIs 43994003906330
    GCN Sequence Number 079605
    GCN Sequence Number Description diphenhyd/phenyleph/acetaminop POWDER POD 25-10-650 ORAL
    HIC3 B3O
    HIC3 Description 1ST GEN ANTIHISTAMINE-DECONGESTANT-ANALGESIC COMB
    GCN 46137
    HICL Sequence Number 035433
    HICL Sequence Number Description DIPHENHYDRAMINE HCL/PHENYLEPHRINE HCL/ACETAMINOPHEN
    Brand/Generic Brand
    Proprietary Name THERAFLU
    Proprietary Name Suffix POWERPODS NIGHTTIME SEVERE COLD
    Non-Proprietary Name ACETAMINOPHEN, DIPHENHYDRAMINE HCL, PHENYLEPHRINE HCL
    Product Type HUMAN OTC DRUG
    Dosage Form POWDER, FOR SOLUTION
    Route ORAL
    Active Ingredient Strength 650; 25; 10
    Active Ingredient Units mg/1; mg/1; mg/1
    Substance Name ACETAMINOPHEN; DIPHENHYDRAMINE HYDROCHLORIDE; PHENYLEPHRINE HYDROCHLORIDE
    Labeler Name GlaxoSmithKline Consumer Healthcare Holdings (US) LLC
    Pharmaceutical Class Adrenergic alpha1-Agonists [MoA], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], alpha-1 Adrenergic Agonist [EPC]
    DEA Schedule n/a
    Marketing Category OTC MONOGRAPH DRUG
    Application Number M012
    Listing Certified Through 2024-12-31

    Package

    NDC 00067-6095-01 (00067609501)

    NDC Package Code 0067-6095-01
    Billing NDC 00067609501
    Package 8 POUCH in 1 CARTON (0067-6095-01) / 1 POWDER, FOR SOLUTION in 1 POUCH (0067-6095-02)
    Marketing Start Date 2018-07-28
    NDC Exclude Flag N
    Pricing Information N/A